Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biogen (BIIB)
NASDAQ:BIIB
Holding BIIB?
Track your performance easily
See the Price Targets and Ratings of:
BIIB Analyst Ratings
Moderate Buy
14 Buy
11 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BIIB Stock 12 Month Forecast
Average Price Target
$247.59
▲(57.05% Upside)
| Highest Price Target$315.00 | Average Price Target$247.59 | Lowest Price Target$180.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
Reiterated
11/21/24
Needham
Downgraded
11/18/24
TD Cowen
Reiterated
11/15/24
Raymond James
Reiterated
11/14/24
Morgan Stanley
Reiterated
11/14/24
Robert W. Baird
Assigned
11/14/24
Jefferies
Reiterated
11/14/24
Wolfe Research
Initiated
11/14/24
J.P. Morgan
Reiterated
11/04/24
Oppenheimer
$270→$255
Buy
61.75%
Upside
Reiterated
10/31/24
Oppenheimer Keeps Their Buy Rating on Biogen (BIIB)
H.C. Wainwright
$300
Buy
90.29%
Upside
Reiterated
10/31/24
Biogen's Promising Pharmaceutical Prospects: Buy Rating Backed by Lecanemab Success and Pipeline Diversification
Leerink Partners
$310→$290
Buy
83.95%
Upside
Reiterated
10/31/24
Biogen (BIIB) PT Lowered to $290 at Leerink PartnersLeerink Partners analyst Marc H. Goodman lowered the price target on Biogen (NASDAQ: BIIB) to $290.00 (from $310.00) while maintaining a Outperform rating.
Bank of America Securities
$250
Hold
58.58%
Upside
Reiterated
10/31/24
Cautious Neutrality: Biogen's Mixed Performance and Uncertain Growth Outlook
Barclays
$190→$180
Hold
14.18%
Upside
Reiterated
10/31/24
Barclays Sticks to Its Hold Rating for Biogen (BIIB)
Best Analysts Covering Biogen
Which Analyst Should I Follow If I Want to Buy BIIB and Sell After:
1 Month
xxx
Success Rate
15/32 ratings generated profit
Average Return
+0.21%
reiterated a xxx
rating 17 hours ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 46.88% of your transactions generating a profit, with an average return of +0.21% per trade.
3 Months
xxx
Success Rate
16/32 ratings generated profit
Average Return
-1.11%
reiterated a xxx
rating 17 hours ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -1.11% per trade.
1 Year
Success Rate
11/38 ratings generated profit
Average Return
-5.70%
reiterated a buy rating 22 days ago
Copying Marc Goodman's trades and holding each position for 1 Year would result in 28.95% of your transactions generating a profit, with an average return of -5.70% per trade.
2 Years
xxx
Success Rate
11/43 ratings generated profit
Average Return
-18.04%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.58% of your transactions generating a profit, with an average return of -18.04% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BIIB Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
2
3
5
14
15
Buy
34
31
30
29
16
Hold
8
8
11
18
20
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
44
42
46
61
51
Each month's total comprises the sum of three months' worth of ratings.
BIIB Financial Forecast
BIIB Stock Forecast FAQ
What is BIIB’s average 12-month price target, according to analysts?
Based on analyst ratings, Biogen’s 12-month average price target is $247.59.
What is BIIB’s upside potential, based on the analysts’ average price target?
Biogen has 57.05% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BIIB a Buy, Sell or Hold?
Biogen has a consensus rating of Moderate Buy which is based on 14 buy ratings, 11 hold ratings and 0 sell ratings.
What is Biogen’s price target?
The average price target for Biogen is $247.59. This is based on 25 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $315.00 ,the lowest forecast is $180.00. The average price target represents 57.05% Increase from the current price of $157.65.
The highest analyst price target is $315.00 ,the lowest forecast is $180.00. The average price target represents 57.05% Increase from the current price of $157.65.
What do analysts say about Biogen?
Biogen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 25 Wall Streets Analysts.
How can I buy shares of BIIB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.